Adia Nutrition (ADIA) Debt Ratio (2024 - 2026)
Adia Nutrition's (ADIA) quarterly Debt Ratio came in at 0.93 in Q1 2026, down 53.83% quarter-over-quarter from 2.02 in Q4 2025.
Analysis
Adia Nutrition (ADIA) Debt Ratio (2024 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Debt Ratio for 3 consecutive years, with 0.93 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.93 in Q1 2026; TTM through Mar 2026 was 0.93, a N/A change from a year earlier, with the FY2025 full-year figure at 2.02, up 264.68% from the prior year.
- Debt Ratio was 0.93 for Q1 2026 at Adia Nutrition, down from 2.02 in the prior quarter.
- Over five years, Debt Ratio peaked at 2.02 in Q4 2025 and troughed at 0.55 in Q4 2024.
- A 3-year average of 1.17 and a median of 0.93 in 2026 frame the typical range for Debt Ratio.
- The widest YoY moves for Debt Ratio: up 264.68% in 2025, down 264.68% in 2025.
- Over 3 years, Debt Ratio stood at 0.55 in 2024, then jumped by 264.68% to 2.02 in 2025, then slumped by 53.83% to 0.93 in 2026.
- The last three Debt Ratio figures came in at 0.93 (Q1 2026), 2.02 (Q4 2025), and 0.55 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | 0.22 |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | 0.09 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 0.05 |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | 0.55 |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | 0.08 |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | 0.27 |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | - |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 0.93 |
| Dec 31, 2025 | 2.02 |
| Dec 31, 2024 | 0.55 |